抗脂综合征中的补充生物标志物 - 量化方法和临床管理的影响
Michael A Cole1, Gloria F Gerber1, Shruti Chaturvedi1
1Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Clinical immunology (Orlando, Fla.)
|November 1, 2023
概括
补充生物标志物对于抗脂综合征 (APS) 管理至关重要. 需要标准化,快速的测试来确定患者谁将受益于补充抑制疗法,以获得更好的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
背景情况:
- 抗脂综合征 (APS) 在很大程度上是由补体系统驱动的.
- 补充系统是一个有希望的治疗目标,特别是在严重的APS病例中.
- 目前对APS的补充测试主要局限于研究,缺乏快速的临床应用.
研究的目的:
- 审查现有的补充生物标志物及其与APS中血栓形成和产科结果的相关性.
- 确定需要可靠,快速转变的生物标志物来预测APS患者的结果,并指导补充抑制疗法.
主要方法:
- 对流体相补充蛋白和激活片段的审查.
- 基于细胞膜的补充试验的评估,包括体内与细胞结合的片段,血液溶解试验和体外功能性基于细胞的试验.
- 对补充基因测序研究的分析.
主要成果:
- 在研究和APS子组之间存在补充测试方法和结果的不一致性.
- 基于细胞的测定或多重生物标记面板显示了APS更大的临床相关性的潜力.
- 补充试验的标准化对于可重复性和临床实用性至关重要.
结论:
- 对于有效的APS管理和个性化治疗策略,需要可靠和快速补充的生物标志物.
- 补充测试的标准化对于将研究结果转化为APS患者的临床实践至关重要.
- 对标准化基于细胞或多重测试的进一步研究可能会改善对不良结果的预测,并指导APS的补充抑制疗法.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
98
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
98
Anticoagulant Drugs: Low-Molecular-Weight Heparins
719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10


